Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ: VNDA · Real-Time Price · USD
5.39
+0.19 (3.65%)
At close: Dec 5, 2025, 4:00 PM EST
5.42
+0.03 (0.46%)
After-hours: Dec 5, 2025, 7:24 PM EST
Vanda Pharmaceuticals Market Cap
Vanda Pharmaceuticals has a market cap or net worth of $318.53 million as of December 5, 2025. Its market cap has increased by 11.03% in one year.
Market Cap
318.53M
Enterprise Value
35.69M
1-Year Change
11.03%
Ranking
Category
Stock Price
$5.39
Market Cap Chart
Since April 12, 2006, Vanda Pharmaceuticals's market cap has increased from $209.50M to $318.53M, an increase of 52.04%. That is a compound annual growth rate of 2.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 318.50M | 14.04% |
| Dec 31, 2024 | 279.30M | 15.03% |
| Dec 29, 2023 | 242.80M | -41.94% |
| Dec 30, 2022 | 418.20M | -52.16% |
| Dec 31, 2021 | 874.10M | 21.64% |
| Dec 31, 2020 | 718.60M | -17.90% |
| Dec 31, 2019 | 875.30M | -36.13% |
| Dec 31, 2018 | 1.37B | 100.69% |
| Dec 29, 2017 | 682.90M | -2.57% |
| Dec 30, 2016 | 700.90M | 75.84% |
| Dec 31, 2015 | 398.60M | -17.90% |
| Dec 31, 2014 | 485.50M | 17.87% |
| Dec 31, 2013 | 411.90M | 294.54% |
| Dec 31, 2012 | 104.40M | -21.97% |
| Dec 30, 2011 | 133.80M | -49.57% |
| Dec 31, 2010 | 265.30M | -13.30% |
| Dec 31, 2009 | 306.00M | 2,200.75% |
| Dec 31, 2008 | 13.30M | -92.75% |
| Dec 31, 2007 | 183.40M | -66.04% |
| Dec 29, 2006 | 540.00M | 157.76% |
View and export this data all the way back to 2006.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.92B |
| Johnson & Johnson | 487.91B |
| AbbVie | 403.87B |
| UnitedHealth Group | 301.87B |
| AstraZeneca | 279.81B |
| Novartis AG | 257.47B |
| Merck & Co. | 251.97B |
| Abbott Laboratories | 217.19B |